Skip to main content

Peer Review reports

From: Additional capecitabine use in early-stage triple negative breast cancer patients receiving standard chemotherapy: a new era? A meta-analysis of randomized controlled trials

Original Submission
19 Apr 2021 Submitted Original manuscript
24 Apr 2021 Author responded Author comments - Feng Ye
Resubmission - Version 2
24 Apr 2021 Submitted Manuscript version 2
26 May 2021 Reviewed Reviewer Report
9 Oct 2021 Reviewed Reviewer Report
25 Oct 2021 Author responded Author comments - Feng Ye
Resubmission - Version 3
25 Oct 2021 Submitted Manuscript version 3
15 Nov 2021 Reviewed Reviewer Report
22 Nov 2021 Reviewed Reviewer Report
10 Jan 2022 Reviewed Reviewer Report
19 Jan 2022 Author responded Author comments - Feng Ye
Resubmission - Version 4
19 Jan 2022 Submitted Manuscript version 4
25 Jan 2022 Reviewed Reviewer Report
18 Feb 2022 Author responded Author comments - Feng Ye
Resubmission - Version 5
18 Feb 2022 Submitted Manuscript version 5
Publishing
22 Feb 2022 Editorially accepted
12 Mar 2022 Article published 10.1186/s12885-022-09326-5

You can find further information about peer review here.

Back to article page